Aktive Positionen von Nicholas Mark Barnes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Celentyx Ltd.
 Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2004 | - |
| Vorstandsvorsitzender | 01.01.2004 | - | |
| Gründer | 01.01.2004 | - | |
| University of Birmingham | Corporate Officer/Principal | - | - |
| The International Union of Basic & Clinical Pharmacology | Corporate Officer/Principal | 04.04.2014 | - |
Karriereverlauf von Nicholas Mark Barnes
Statistik
International
| Vereinigtes Königreich | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Celentyx Ltd.
Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Health Technology |
| The International Union of Basic & Clinical Pharmacology |
- Börse
- Insiders
- Nicholas Mark Barnes
- Erfahrung
